Truist Financial Corp Vertex Pharmaceuticals Inc Transaction History

Truist Financial Corp

$65 Billion
Q2 2024

A detailed history of Truist Financial Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Truist Financial Corp holds 218,641 shares of VRTX stock, worth $104 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

218,641

Previous 223,111 2.0%

Holding current value

$104 Million

Previous $93.3 Million 9.89%

% of portfolio

0.16%

Previous 0.14%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 20, 2024	SELL	$392.81 - $485.53 $1.76 Million - $2.17 Million	-4,470 Reduced 2.0%	218,641 $102 Million
Q1 2024 May 10, 2024	SELL	$407.69 - $446.08 $915,264 - $1 Million	-2,245 Reduced 1.0%	223,111 $93.3 Million
Q4 2023 Feb 02, 2024	SELL	$343.0 - $410.68 $585,501 - $701,030	-1,707 Reduced 0.75%	225,356 $91.7 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $19.7 Million - $21.1 Million	58,219 Added 34.48%	227,063 $79 Million
Q2 2023 Aug 01, 2023	BUY	$314.42 - $351.91 $2.56 Million - $2.86 Million	8,141 Added 5.07%	168,844 $59.4 Million
Q1 2023 May 05, 2023	SELL	$283.23 - $323.1 $3.04 Million - $3.47 Million	-10,741 Reduced 6.27%	160,703 $50.6 Million
Q4 2022 Feb 17, 2023	BUY	$285.76 - $321.48 $18 Million - $20.2 Million	62,866 Added 57.9%	171,444 $49.5 Million
Q3 2022 Oct 26, 2022	BUY	$273.83 - $305.53 $476,738 - $531,927	1,741 Added 1.63%	108,578 $31.4 Million
Q2 2022 Jul 22, 2022	SELL	$234.96 - $292.55 $972,029 - $1.21 Million	-4,137 Reduced 3.73%	106,837 $30.1 Million
Q1 2022 Apr 22, 2022	BUY	$221.42 - $260.97 $5.94 Million - $7 Million	26,836 Added 31.9%	110,974 $29 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $511,027 - $645,100	2,887 Added 3.55%	84,138 $18.5 Million
Q3 2021 Nov 05, 2021	BUY	$181.39 - $202.99 $7.89 Million - $8.83 Million	43,511 Added 115.29%	81,251 $14.7 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $15,936 - $18,793	85 Added 0.23%	37,740 $7.61 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $386,299 - $450,284	-1,866 Reduced 4.72%	37,655 $8.09 Million
Q4 2020 Feb 18, 2021	SELL	$207.01 - $276.09 $578,385 - $771,395	-2,794 Reduced 6.6%	39,521 $9.34 Million
Q3 2020 Nov 05, 2021	BUY	$255.65 - $303.1 $21,730 - $25,763	85 Added 0.2%	42,315 $11.5 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $700,481 - $830,494	2,740 Added 6.94%	42,230 $11.5 Million
Q2 2020 Nov 16, 2021	BUY	$225.48 - $295.8 $12,175 - $15,973	54 Added 0.14%	39,490 $11.5 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $1.02 Million - $1.34 Million	4,530 Added 12.98%	39,436 $11.4 Million
Q1 2020 Nov 05, 2021	BUY	$199.77 - $247.81 $10,787 - $13,381	54 Added 0.15%	34,906 $8.31 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $63,726 - $79,051	-319 Reduced 0.91%	34,852 $8.29 Million
Q4 2019 Nov 16, 2021	BUY	$166.71 - $223.91 $12,336 - $16,569	74 Added 0.21%	35,171 $7.7 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $4.25 Million - $5.71 Million	25,503 Added 265.82%	35,097 $7.69 Million
Q3 2019 Oct 31, 2019	BUY	$166.23 - $187.09 $13,797 - $15,528	83 Added 0.87%	9,594 $1.63 Million
Q2 2019 Jul 24, 2019	SELL	$164.61 - $190.37 $28,312 - $32,743	-172 Reduced 1.78%	9,511 $1.75 Million
Q1 2019 Apr 23, 2019	SELL	$163.73 - $194.7 $15,390 - $18,301	-94 Reduced 0.96%	9,683 $1.78 Million
Q4 2018 Jan 22, 2019	SELL	$151.91 - $192.21 $104,058 - $131,663	-685 Reduced 6.55%	9,777 $1.62 Million
Q3 2018 Oct 17, 2018	BUY	$167.73 - $192.74 $17,443 - $20,044	104 Added 1.0%	10,462 $2.02 Million
Q2 2018 Jul 26, 2018	SELL	$145.72 - $169.96 $155,483 - $181,347	-1,067 Reduced 9.34%	10,358 $1.76 Million
Q1 2018 Apr 20, 2018	BUY	$151.6 - $177.13 $34,413 - $40,208	227 Added 2.03%	11,425 $1.86 Million
Q4 2017 Jan 29, 2018	BUY	$137.28 - $155.55 $12,629 - $14,310	92 Added 0.83%	11,198 $1.68 Million
Q3 2017 Oct 23, 2017	BUY	$148.13 - $162.24 $1.65 Million - $1.8 Million	11,106	11,106 $1.69 Million

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Vertex Pharmaceuticals Inc Transaction History